BIOMAT Database Logo BIOMAT Database Logo

Antithrombin III immunoelectrophoretic pattern in DIC. 1978

G Nalli, and I Majolino, and P Panizza, and E Ascari

UI MeSH Term Description Entries
D007122 Immunoelectrophoresis A technique that combines protein electrophoresis and double immunodiffusion. In this procedure proteins are first separated by gel electrophoresis (usually agarose), then made visible by immunodiffusion of specific antibodies. A distinct elliptical precipitin arc results for each protein detectable by the antisera.
D004211 Disseminated Intravascular Coagulation A disorder characterized by procoagulant substances entering the general circulation causing a systemic thrombotic process. The activation of the clotting mechanism may arise from any of a number of disorders. A majority of the patients manifest skin lesions, sometimes leading to PURPURA FULMINANS. Consumption Coagulopathy,Coagulation, Disseminated Intravascular,Disseminated Coagulation, Intravascular,Intravascular Coagulation, Disseminated,Intravascular Disseminated Coagulation,Coagulation, Intravascular Disseminated,Coagulations, Disseminated Intravascular,Coagulations, Intravascular Disseminated,Coagulopathies, Consumption,Coagulopathy, Consumption,Consumption Coagulopathies,Disseminated Coagulations, Intravascular,Disseminated Intravascular Coagulations,Intravascular Coagulations, Disseminated,Intravascular Disseminated Coagulations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000990 Antithrombin III A plasma alpha 2 glycoprotein that accounts for the major antithrombin activity of normal plasma and also inhibits several other enzymes. It is a member of the serpin superfamily. Heparin Cofactor I,Antithrombin III-Alpha,Atenativ,Heparin Co-Factor I,Kybernin,Serpin C1,Thrombate III,Antithrombin III Alpha,Antithrombin IIIAlpha,Cofactor I, Heparin,Heparin Co Factor I

Related Publications

G Nalli, and I Majolino, and P Panizza, and E Ascari
Treatment of DIC with antithrombin III concentrates.
January 1983, Bibliotheca haematologica,
G Nalli, and I Majolino, and P Panizza, and E Ascari
Antithrombin III immunoprecipitation pattern.
January 1977, Thrombosis research,
G Nalli, and I Majolino, and P Panizza, and E Ascari
Antithrombin III Trento. A 'new' congenital AT III abnormality with a peculiar crossed-immunoelectrophoretic pattern in the absence of heparin.
January 1984, Acta haematologica,
G Nalli, and I Majolino, and P Panizza, and E Ascari
Immunoelectrophoretic quantitation of antithrombin III. Electroimmunodiffusion in agarose gels containing heparin.
January 1977, International journal of peptide and protein research,
G Nalli, and I Majolino, and P Panizza, and E Ascari
Substitution therapy with an antithrombin III concentrate in shock and DIC.
August 1982, Thrombosis research,
G Nalli, and I Majolino, and P Panizza, and E Ascari
Substitution of antithrombin III in shock and DIC: a randomized study.
July 1985, Thrombosis research,
G Nalli, and I Majolino, and P Panizza, and E Ascari
Influence of hirudin on the consumption of antithrombin III in experimental DIC.
January 1988, Folia haematologica (Leipzig, Germany : 1928),
G Nalli, and I Majolino, and P Panizza, and E Ascari
Low antithrombin III in neonatal shock: DIC or non-specific protein depletion?
December 1986, European journal of pediatrics,
G Nalli, and I Majolino, and P Panizza, and E Ascari
[The clinical efficacy of antithrombin III concentrate in infections complicated by DIC].
November 1985, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
G Nalli, and I Majolino, and P Panizza, and E Ascari
[Studies on antithrombin III. II. The role for antithrombin III (ATIII) in the control of disseminated intravascular coagulation (DIC). (The effect of the administration of ATIII concentrates in experimental DIC and in clinical DIC) (author's transl)].
October 1980, Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society,
Copied contents to your clipboard!